Methimazole for Graves' Disease Linked to Acute Pancreatitis | oneGRAVESvoice

welcome to oneGRAVESvoice

- a positively charged Graves' disease and thyroid eye disease community.
  • join today!

Methimazole for Graves’ Disease Linked to Acute Pancreatitis


The treatment of Graves’ disease with the antithyroid drug methimazole is associated with a significantly increased risk of acute pancreatitis, and although cases are rare, the risk justifies warnings about this potential adverse event, according to a nationwide controlled study in Denmark spanning more than 20 years.

“The data are very strong and convincing, (showing) that the risk of pancreatitis is of the same order as that of agranulocytosis, which we have warned against and informed about for decades,” first author Laszlo Hegedus, MD, president of the European Thyroid Association, told Medscape Medical News.

“So not taking this seriously would be extremely arrogant,” he said after presenting his findings at the 89th American Thyroid Association (ATA) Annual Meeting.

 

Methimazole For Graves’ Disease Linked To Acute Pancreatitis
Font Resize

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close